Robert Madelin

Robert Madelin was a UK and then EU civil servant 1979-2016, serving as European Commission Director General for Health 2004-10. Robert is since 2016 the Chairman of FIPRA International, a micro-multinational public affairs consultancy. He also sits on the International Advisory Council of Teladoc Health Inc, a US-headquartered telemedicine company, is a non-executive director at Médisanté Group AG, a Swiss medtech startup and advises PlusValue Advisory Ltd, a Italy-UK startup which specialises in social impact investing. British by birth, French by marriage, Robert was educated at the Royal Grammar School, High Wycombe and Magdalen College, Oxford, as well as at the French Ecole Nationale d’Administration. He has been a visiting Fellow at the Oxford University Department of Politics and International Relations and at the Cambridge University Centre for Science and Policy. Robert is an Honorary Fellow of the Royal College of Physicians of London and an Honorary Doctor of the University of Edinburgh. Recent publications include ‘Opportunity Now: Europe’s Mission to Innovate’ (2016), ‘An ethical framework for a good AI society’ (2018) and ‘On good AI governance’ (2019).